28th Apr 2011 07:00
Immunodiagnostic Systems Holdings PLC ("IDS" or "the Company")
28 April 2011
VOTING RIGHTS AND CAPITAL
IDS, a leading producer of diagnostic testing kits, makes the following announcement in accordance with the Disclosure and Transparency Rules.
The Company's issued share capital consists of 28,236,915 ordinary shares with a nominal value of 2p each ('Ordinary Shares'). The Company does not hold any Ordinary Shares in Treasury.
Therefore, the total number of voting rights in the Company is 28,236,915.
The figure of 28,236,915 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.
For further information:
Immunodiagnostic Systems Holdings plc | Tel: 0191 519 0660 |
Ian Cookson, Chief Executive Officer | |
Paul Hailes, Finance Director | |
Brewin Dolphin | Tel: 0845 213 4730 |
Matt Davis | |
Sean Wyndham-Quin | |
Walbrook PR Ltd | Tel: 020 7933 8787 |
Paul McManus / Fiona Henson | Mob: 07980 541 893 / 07886 335 992 |
Related Shares:
IDH.L